StarFill Regulatory Status: Essential Insights for Professional Sourcing

StarFill is a range of hyaluronic acid dermal fillers manufactured by JETEMA in South Korea. Sourcing these products for professional aesthetic practice requires due diligence regarding their legal and quality assurances. The regulatory framework governs manufacturing standards, product safety, and distribution legality across various international markets. For professionals, this compliance ensures product integrity and supports clinic reputation.

Like other hyaluronic acid dermal fillers, such as LEXYAL, StarFill's market acceptance relies heavily on adherence to specific national and international health regulations. The wholesale price for StarFill is illustratively around $71.2 per unit, with volume tiers offering progressive reductions: 11 units at 4% off, 21 units at 5% off, 31 units at 6% off, and 51+ units at 8% off.

The primary certifications relevant to StarFill, as a South Korean-manufactured injectable, include:

• KFDA Approval: As a product of JETEMA, StarFill holds approval from the Korean Ministry of Food and Drug Safety (KFDA). This signifies compliance with stringent domestic manufacturing and safety standards for distribution within South Korea.
• CE Mark: [VERIFY: StarFill CE Mark status]. A CE Mark (Conformité Européenne) is essential for legal distribution and sale within the European Union (EU) and other European Economic Area (EEA) countries. This mark indicates that the product meets EU health, safety, and environmental protection standards.
• GMP (Good Manufacturing Practice): [VERIFY: StarFill GMP certification]. Adherence to GMP guidelines is critical for any injectable product, ensuring consistent quality and control in manufacturing processes.
• ISO Certifications: [VERIFY: StarFill ISO certification, e.g., ISO 13485 for medical devices]. ISO standards provide an international benchmark for quality management systems.

For clinics operating in the European Union, the presence of a valid CE Mark on StarFill is the prerequisite for legal import and professional use. The CE mark attests that the product aligns with the requirements of the Medical Device Regulation (MDR) or Medical Device Directive (MDD), as applicable. Without this, parallel imports or non-compliant sourcing carries significant risks.

In the United Kingdom, following Brexit, products typically require a UKCA (UK Conformity Assessed) mark or an accepted CE mark, depending on specific transitional arrangements. Professionals should verify the current status of StarFill's UKCA certification or the acceptance of its CE mark for legal use. For comparisons, consider reviewing information for other certified fillers like those found in the Hyaluronic acid dermal filler catalog.

Market access for StarFill in the Gulf Cooperation Council (GCC), Latin America (LATAM), and Asia-Pacific (APAC) regions varies by country, each having its own regulatory bodies and approval processes. For example, countries within the GCC often require specific Ministry of Health (MOH) or Saudi Food & Drug Authority (SFDA) approvals. LATAM markets, such as Brazil, Mexico, or Colombia, have agencies like ANVISA, COFEPRIS, and INVIMA respectively, which demand local registration.

In the APAC region, authorities such as the TGA in Australia, HSA in Singapore, and TFDA in Thailand dictate local compliance. Clinics must rely on their suppliers to provide evidence of these specific regional approvals for StarFill to ensure lawful procurement and use. This complex landscape underscores the need for vigilant sourcing practices, similar to insights provided in regulatory guides for products like Yvoire Volume Plus Regulatory Status: Essential Insights for.

While competitive pricing can be attractive, sourcing StarFill through unauthorized or parallel import channels presents substantial risks. These may include products lacking proper cold chain storage, nearing expiry, or being counterfeit. Such products typically lack official manufacturer warranties or support, and their legal status for professional use may be compromised. This can lead to compliance issues for the clinic.

Genuine products ensure patient safety and maintain professional standards. It is crucial to distinguish between cost savings from volume tier discounts, as seen with EPTQ S300: A Professional Guide to Wholesale Pricing and Cli, and risks associated with unregulated sources.

To ensure legitimate sourcing of StarFill, clinics must demand specific documentation from their suppliers. This includes:

• Certificate of Authenticity: Proof that the product is an original StarFill item from JETEMA.
• Certificate of Analysis (CoA): Batch-specific quality control documentation.
• Lot Numbers and Expiry Dates: Clearly visible and traceable.
• Cold Chain Verification: Evidence of proper storage and transport conditions.
• Customs Declarations and Import Licenses: Demonstrating legal entry into the target market.

Reputable suppliers, offering products like Elasty Plus 1CC, will readily provide this information, affirming their commitment to legal and ethical distribution channels.